Skip to main content
Emerging Infectious Diseases logoLink to Emerging Infectious Diseases
. 2001 May-Jun;7(3):442–443. doi: 10.3201/eid0703.010313

Third-generation cephalosporin resistance in Shigella sonnei, Argentina.

M Radice 1, C Gonzéález 1, P Power 1, M C Vidal 1, G Gutkind 1
PMCID: PMC2631805  PMID: 11384523

Abstract

Shigella sonnei resistant to cefotaxime (but not to ceftazidime) was isolated for the first time in stool samples from a pediatric patient with vomiting and bloody diarrhea in northern Argentina. Microbiologic and biochemical tests confirmed the presence of an extended spectrum beta-lactamase displaying an apparent isoelectric point value of 8.2.

Full Text

The Full Text of this article is available as a PDF (41.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahamed J., Kundu M. Molecular characterization of the SHV-11 beta-lactamase of Shigella dysenteriae. Antimicrob Agents Chemother. 1999 Aug;43(8):2081–2083. doi: 10.1128/aac.43.8.2081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bauernfeind A., Casellas J. M., Goldberg M., Holley M., Jungwirth R., Mangold P., Röhnisch T., Schweighart S., Wilhelm R. A new plasmidic cefotaximase from patients infected with Salmonella typhimurium. Infection. 1992 May-Jun;20(3):158–163. doi: 10.1007/BF01704610. [DOI] [PubMed] [Google Scholar]
  3. Birnboim H. C., Doly J. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res. 1979 Nov 24;7(6):1513–1523. doi: 10.1093/nar/7.6.1513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Mates A., Eyny D., Philo S. Antimicrobial resistance trends in Shigella serogroups isolated in Israel, 1990-1995. Eur J Clin Microbiol Infect Dis. 2000 Feb;19(2):108–111. doi: 10.1007/s100960050439. [DOI] [PubMed] [Google Scholar]
  5. Power P., Radice M., Barberis C., de Mier C., Mollerach M., Maltagliatti M., Vay C., Famiglietti A., Gutkind G. Cefotaxime-hydrolysing beta lactamases in Morganella morganii. Eur J Clin Microbiol Infect Dis. 1999 Oct;18(10):743–747. doi: 10.1007/s100960050391. [DOI] [PubMed] [Google Scholar]
  6. Prats G., Mirelis B., Llovet T., Muñoz C., Miró E., Navarro F. Antibiotic resistance trends in enteropathogenic bacteria isolated in 1985-1987 and 1995-1998 in Barcelona. Antimicrob Agents Chemother. 2000 May;44(5):1140–1145. doi: 10.1128/aac.44.5.1140-1145.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Replogle M. L., Fleming D. W., Cieslak P. R. Emergence of antimicrobial-resistant shigellosis in Oregon. Clin Infect Dis. 2000 Mar;30(3):515–519. doi: 10.1086/313715. [DOI] [PubMed] [Google Scholar]
  8. Rossi A., Galas M., Binztein N., Rivas M., Caffer M. I., Corso A., Radice M., Gutkind G. Unusual multiresistant Vibrio cholerae O1 El Tor in Argentina. Lancet. 1993 Nov 6;342(8880):1172–1173. doi: 10.1016/0140-6736(93)92155-m. [DOI] [PubMed] [Google Scholar]
  9. Rossi A., Lopardo H., Woloj M., Picandet A. M., Mariño M., Galds M., Radice M., Gutkind G. Non-typhoid Salmonella spp. resistant to cefotaxime. J Antimicrob Chemother. 1995 Oct;36(4):697–702. doi: 10.1093/jac/36.4.697. [DOI] [PubMed] [Google Scholar]
  10. WATANABE T., FUKASAWA T. Episome-mediated transfer of drug resistance in Enterobacteriaceae. I. Transfer of resistance factors by conjugation. J Bacteriol. 1961 May;81:669–678. doi: 10.1128/jb.81.5.669-678.1961. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

RESOURCES